321 Columbus Avenue
168 articles with InspireMD Ltd.
MGuard(TM), InspireMD Ltd.'s Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
InspireMD Ltd. Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
InspireMD Ltd. Announces Positive 6-Month Efficacy and Safety Results of the MGuard(TM) Coronary Stent